Malignant Genitourinary System Neoplasm

Malignant Genitourinary System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

15,536 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 3,543
Recruiting: 1,928
Ph III recruiting: 225
Growth YoY: +16.1%
Industry share: 22%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,963)

clinicaltrialsPublishedShowing 1–33 of 33 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06952660	Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer	recruiting	Phase 4	100	PfizerINDUSTRY	2	Sep 25, 2026	clinicaltrials
NCT05979493	QL Block in Laparoscopic Myomectomy	recruiting	Phase 4	80	Joseph Findley MDOTHER	1	Sep 11, 2026	clinicaltrials
NCT07569926